Orion, Mylan settle patent dispute over Parkinson's drug Stalevo

HELSINKI, July 25 Thu Jul 25, 2013 4:37am EDT

HELSINKI, July 25 (Reuters) - Finnish drug maker Orion said that it settled a patent lawsuit in the United States against Mylan Pharmaceuticals over Mylan's application to sell a generic version of Orion's Parkinson's drug Stalevo.

Orion did not disclose the terms of their settlement, but said Mylan would be authorised to launch generic versions of the Stalevo drug.

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.